American Journal of Obstetrics & Gynecology
Volume 188, Issue 6 , Pages 1551-1555 , June 2003

Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes

Presented at the Sixty-Ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 22-27, 2002, Rancho Mirage, Calif.

References 

  1. American College of Obstetricians and Gynecologists . Management of herpes in pregnancy. Washington (DC): The College; 1999; Practice bulletin No.: 8
  2. Whitely R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, et al.  Predictors of morbidity and mortality in neonates with herpes simplex infections: the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991;324:450–454
  3. Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, et al.  Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 1991;324:1247–1252
  4. Prober CG, Corey L, Brown ZA, Hensleigh PA, Frenkel LM, Bryson YJ, et al.  The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis. 1992;15:1031–1038
  5. Utley K, Bromberger P, Wagner L, Schneider H. Management of primary herpes in pregnancy complicated by ruptured membranes and extreme prematurity: case report. Obstet Gynecol. 1987;69:471–473
  6. Ray DA, Evans AT, Elliot JP, Freeman RK. Maternal herpes infection complicated by prolonged premature rupture of membranes. Am J Perinatol. 1985;2:96–100
  7. Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infection. N Engl J Med. 1987;316:240–244
  8. Monif GRG, Kellner KR, Donnelly WH. Congenital herpes simplex type II infection. Am J Obstet Gynecol. 1985;152:1000–1002
  9. Barefoot KH, Little GA, Ornvold KT. Fetal demise due to herpes simplex virus: an illustrated case report. J Perinatol. 2002;22:86–88
  10. Pregnancy outcomes following system prenatal acyclovir exposure: June 1,1984–June 30, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:806–809
  11. Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial. Infect Dis Obstet Gynecol. 2001;9:75–80
  12. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol. 1996;87:69–73
  13. Gutierrez KM, Halpern FMS, Maldonado Y, Arvin AM. The epidemiolgy of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis. 1999;180:199–202
  14. Kulhanjian JA, Soroush V, Au DS, Bronzan RN, Yasukawa LL, Weyland LE, et al.  Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med. 1992;326:946–947
  15. Boucher FD, Yasukawa LL, Bronzan RN, Hensleigh PA, Arvin AM, Prober CG. A prospective evaluation of primar gential herpes simplex virus type 2 infections acquired during pregnancy. Pediatr Infect Dis J. 1990;9:499–504

 Reprint requests: Carol A. Major, MD, Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, 101 The City Drive, Building 25, Route 81, Orange, CA 92668.

PII: S0002-9378(03)00342-9

doi: 10.1067/mob.2003.388

American Journal of Obstetrics & Gynecology
Volume 188, Issue 6 , Pages 1551-1555 , June 2003